Researchers Discover Evidence to Support Theory of 'Buckyball' Formation
News Sep 24, 2013
Technically known as fullerenes, these spherical carbon molecules have shown great promise for uses in medicine, solar energy, and optoelectronics. One small hiccup, however, has hindered development of a deeper understanding of these peculiar structures over the past few decades: No one knows exactly how they are formed.
Although several processes for making fullerenes are well documented, there are two competing theories about the mechanisms at work at the molecular level. The first and oldest is the “bottom-up” theory, which says these carbon cages are built atom-by-atom, like the slow construction of a Lego model. The second, more recent theory takes a “top-down” approach, suggesting instead that fullerenes are formed when much larger structures break into constituent parts.
After several years of debate with little more than computational models in support of how the top-down theory might work, researchers led by Harry Dorn, a professor at the Virginia Tech Carilion Research Institute, report the discovery of the missing link: asymmetrical fullerenes that are formed from larger structures that appear to be in the process of settling into stable fullerenes.
“Understanding the molecular mechanics of how fullerenes and their many variations are formed is not just a curiosity,” said Dorn, who has been researching metallofullerenes – fullerenes with a few atoms of metal held within – for more than two decades. “It would give us insights into new, better ways to prepare them. Fullerenes and metallofullerenes are already involved in hundreds of biomedical studies. The ability to create large numbers of a wide variety of metallofullerenes would be a giant building block that would take the field to new heights.”
The medicinal promise of metallofullerenes stems from the atoms of metal that are caged within. Because the metal atoms are trapped in a cage of carbon, they do not react with the outside world, making their side-effect risks low in both number and intensity.
For example, one particular metallofullerene with gadolinium at its core has been shown to be up to 40 times better as a contrast agent in magnetic resonance imaging scans for diagnostic imaging than options now commercially available. Current experiments are also directed at using metallofullerenes carrying therapeutic radioactive ions to target cancer tissue.
“A better understanding of the formation of fullerenes and metallofullerenes may allow the development of new contrast agents for magnetic resonance imaging at commercial-level quantities,” said Jianyuan Zhang of Beijing, a graduate student in Dorn’s laboratory and the first author of the paper. “These larger quantities will facilitate a next generation of contrast agents with multiple targets.”
Dorn’s new study hinges on the isolation and purification of approximately 100 micrograms – roughly the size of several specks of pepper – of a particular metallofullerene consisting of 84 carbon atoms with two additional carbon atoms and two yttrium atoms trapped inside. When Dorn and his colleagues determined the metallofullerene’s exact structure using nuclear magnetic resonance imaging and single crystal X-ray analysis, they made a startling discovery. The asymmetrical molecule could theoretically collapse to form nearly every known fullerene and metallofullerene. All the processes would require would be a few minor perturbations – the breaking of only a few molecular bonds – and the cage would become highly symmetrical and stable.
This insight, Dorn said, supports the theory that fullerenes are formed from graphene – a single sheet of carbon just one atom thick – when key molecular bonds begin to break down. And although the study focuses on fullerenes with yttrium trapped inside, it also shows that the carbon distribution looks similar for empty cages, suggesting the formation process of regular fullerenes is the same.
“Not only are the findings presented in Dr. Dorn’s paper extremely interesting, but the study represents a real milestone in the field,” said Takeshi Akasaka, a professor of chemistry at the University of Tsukuba in Japan and an internationally renowned scientist in metallofullerenes, who was not involved in the research. “The study presents physical evidence for a process of metallofullerene creation that most scientists in the field initially scoffed at.”
“Ever since it was discovered that fullerenes were formed from asteroids colliding with Earth and fullerenes were found in interstellar space, scientists have questioned the bottom-up theory of their formation,” said Dorn. “With this study, we hope to be that much closer to understanding their formation and creating entirely new classes of fullerenes and metallofullerenes that could be useful in medicine as well as in other fields that haven’t even occurred to us yet.”
“Dr. Dorn’s insight into the fundamental process whereby fullerenes are formed is a major contribution to the field,” said Michael Friedlander, executive director of the Virginia Tech Carilion Research Institute. “Understanding the molecular steps in their formation is key to realizing fully the potential of this versatile and potentially potent family of chemicals in medicine. Dr. Dorn’s contributions to understanding these molecules are paving the way for the formulation of targeted novel diagnostics, therapeutics, and the combination of both — theranostics. This approach will provide an important component for tomorrow’s arsenal of precision medicine.”
Homemade Microscope Reveals How Viruses Cling to Our DNANews
Using a homemade, high-tech microscope, scientists at the School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.READ MORE
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug DiscoveryNews
Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.READ MORE
Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity TreatmentNews
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.READ MORE